lipolysis raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-30 and is reviewed periodically as new material appears.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide fragment | Not a full hormone |
| Molecular target | Proposed adipose tissue lipolysis | Receptor details uncertain |
| Typical research dose | Not established for clinical use | Doses vary across studies |
| Stability in solution | Limited; store cold | Avoid repeated freeze-thaw |
| Regulatory status | Not approved as a drug | Varies by country |
Increasing the complexity of in vitro systems to reproduce tissues and interactions between them (as in "human on chip" systems) Using mathematical modeling to numerically simulate the behavior of the complex system, where the in vitro data provide model parameter values These two approaches are not incompatible; better in vitro systems provide better data to mathematical models. However, increasingly sophisticated in vitro experiments collect increasingly numerous, complex, and challenging data to integrate. Mathematical models, such as systems biology models, are much needed here.
=== Women === Hyperandrogenism, especially high levels of testosterone, can cause serious adverse effects if left untreated. High testosterone levels are associated with other health conditions such as obesity, hypertension, amenorrhea (cessation of menstrual cycles), and ovulatory dysfunction, which can lead to infertility. Prominent signs of hyperandrogenism are hirsutism (unwanted growth of hair, especially in the abdominal region and on the back), adult acne, deepening of the voice, and alopecia (balding). Hyperandrogenism has also been observed to increase insulin tolerance, which can lead to type two diabetes and dyslipidemia, such as high cholesterol. These effects may have psychological impacts, sometimes leading to social anxiety and depression, especially in adolescent girls and young women. Paired with obesity and hirsutism, it can cause the individual to have low self-esteem.
Histoire et dictionnaire de Paris [History and dictionary of Paris] (in French). Paris: Éditions Robert-Laffont. Auguste, Jal (1872). Dictionnaire critique de biographie et d'histoire [Critical Dictionary of Biography and History] (in French). Paris: Éditions Plon. Piot, Eugène (1873). État civil de quelques artistes français [Marital status of some French artists] (in French). Paris: Librairie Pagnerre.
=== Hong Kong === During British rule, Chinese medicine practitioners in Hong Kong were not recognized as "medical doctors", which meant they could not issue prescription drugs, give injections, and such. However, TCM practitioners could register and operate TCM as "herbalists". The Chinese Medicine Council of Hong Kong, established in 1999, regulates compounds and professional standards for TCM practitioners. All TCM practitioners in Hong Kong are required to register with the council. The eligibility for registration includes a recognised 5-year university degree of TCM, a 30-week minimum supervised clinical internship, and passing the licensing exam. The approved Chinese medicine institutions are Hong Kong University, Chinese University of Hong Kong and Hong Kong Baptist University.
== Peptides-to-Drugs (P2D) platform == Based on its P2D platform, Jerini established several in-house development programs, to address indications within the ophthalmology, oncology, and inflammatory therapeutic areas. The most advanced of these programs targeted age-related macular degeneration (AMD), the leading cause of vision loss and blindness in people over the age of 55 in developed countries. Jerini's compound (JSM 6427) has shown significant efficacy in combating disease progression in preclinical models. Jerini's proprietary Peptides-to-Drugs (P2D) technology was used to identify peptide drug lead structures and systematically transform them into peptidomimetic (injectable) and small-molecule (oral) drugs, depending on the indication. This enabled Jerini to develop novel drug candidates for diseases that were difficult to access using traditional drug discovery methods. The ability to produce both peptidomimetics and small molecule drugs as drug candidates has enabled the simultaneous development of drugs for acute and chronic treatments against the same target molecule (target).
Sources: en.wikipedia.org
Iso-LSD, also known as d-iso-LSD, (+)-iso-LSD, or (5R-8S)-LSD, as well as N,N-diethylisolysergamide, is a serotonin receptor modulator of the lysergamide family related to lysergic acid diethylamide (LSD). It is the 8-position epimer of LSD, with iso-LSD being 8α (8S) and LSD being 8β (8R). Iso-LSD is also the N,N-diethyl derivative of isoergine (isolysergic acid amide; iso-LSA), a constituent found in morning glory seeds. Iso-LSD is one of four possible stereoisomers of LSD.
Pseudoephedrine is available by itself over-the-counter in the form of 30 and 60 mg immediate-release and 120 and 240 mg extended-release oral tablets in the United States. Pseudoephedrine is also available over-the-counter and prescription-only in combination with numerous other drugs, including antihistamines (acrivastine, azatadine, brompheniramine, cetirizine, chlorpheniramine, clemastine, desloratadine, dexbrompheniramine, diphenhydramine, fexofenadine, loratadine, triprolidine), analgesics (acetaminophen, codeine, hydrocodone, ibuprofen, naproxen), cough suppressants (dextromethorphan), and expectorants (guaifenesin). Pseudoephedrine has been used in the form of the hydrochloride and sulfate salts and in a polistirex form. The drug has been used in more than 135 over-the-counter and prescription formulations. Many prescription formulations containing pseudoephedrine have been discontinued over time.
=== Avionics, military and government === In 1929 Vincent Bendix branched out into aeronautics and restructured the company as "Bendix Aviation" to reflect the new product lines. Bendix Aviation was founded as a holding company for the assets of Delco Aviation Corporation, Eclipse Machine Company, Stromberg Carburetor Company, and other aircraft accessory manufacturers. Bendix supplied aircraft manufacturers with hydraulic systems, for braking and flap activation, and introduced the pressure carburetor. It made a wide variety of electrical and electronic instruments for aircraft. From 1931, it sponsored the Bendix Trophy, a transcontinental U.S. point-to-point race intended to encourage the development of commercial aircraft. During and after World War II Bendix made radar equipment of various types. Bendix ranked 17th among United States corporations in the value of wartime production contracts. Bendix aviation masks and gauges were modified and tested for use in diving and hyperbaric applications. In the 1950s, Bendix and its successors managed United States Atomic Energy Commission facilities in Kansas City, Missouri and Albuquerque, New Mexico. These facilities procured non-nuclear components for nuclear weapons.
“Chemoinformatics and Molecular Simulation”; “Chemistry of Supramolecular Nano- and Biosystems”; “Methods of Analytical Chemistry”; “Physical-Chemical Methods in Chemistry”; “Petrochemistry and Catalysis”. Total number of students taking Bachelor, Specialist and master's degree programs is 472 (as of January, 2016).Departments of the Institute of Chemistry educate postgraduates in the following majors: 02.00.01 – Inorganic Chemistry; 02.00.02 – Analytical Chemistry; 02.00.03 – Organic Chemistry; 02.00.04 – Physical Chemistry; 02.00.08 – Chemistry of Organoelement Compounds. There are two dissertation councils functioning in the Institute of Chemistry for thesis defence in chemical sciences: Д 212.081.03 under the Federal State Autonomous Institution of Higher Education “Kazan (Volga Region) Federal University”; majors allowed for defence: 02.00.01 – Inorganic Chemistry; 02.00.08 – Chemistry of Organoelement Compounds; Chairman of the Council is Professor Vladimir I. Galkin, Doctor of Chemistry;
Sources: en.wikipedia.org
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.
Because it is a fragment rather than full growth hormone, it is generally described as lacking growth-promoting effects. Some studies suggest it may influence fat metabolism without the same systemic growth effects, though evidence is limited.
Human trials have measured body weight, fat mass, lean mass, lipid levels, and adverse events. Most have been small or short-term, so conclusions about long-term outcomes are limited.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.